ORCA
Online Research @ Cardiff

Clear Cookie - decide language by browser settings

Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study

Reich, K., Gooderham, M., Bewley, A., Green, L., Soung, J., Petric, R., Marcsisin, J., Cirulli, J., Chen, R. and Piguet, V. 2017. Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study. Journal of the European Academy of Dermatology and Venereology 32 (3) , pp. 397-402. 10.1111/jdv.14738

[thumbnail of Reich_et_al-2018-Journal_of_the_European_Academy_of_Dermatology_and_Venereology.pdf]

Preview

PDF - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (195kB) | Preview

Official URL: http://dx.doi.org/10.1111/jdv.14738

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Publisher:	Wiley
ISSN:	0926-9959
Date of First Compliant Deposit:	19 October 2018
Date of Acceptance:	8 December 2017
Last Modified:	06 May 2023 02:06
URI:	https://orca.cardiff.ac.uk/id/eprint/116016

Citation Data

Cited 36 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item

Altmetric

Dimensions

Download Statistics

Downloads

Downloads per month over past year

View more statistics

CORE (COnnecting REpositories)